Mepolizumab for treating severe eosinophilic asthma (review of technology appraisal guidance TA431) [ID3750]
Mepolizumab for treating severe eosinophilic asthma (review of technology appraisal guidance TA431) [ID3750]
National Institute for Health and Care Research
O'Toole, Brian
cd14cb1f-97e3-4f47-b701-1047eb8e1415
Nikram, Elham
42b3d70c-eebc-4e1b-a0d7-23f69e4e8742
Robinson, Sophie
ca6f6393-f165-4a34-98a5-d90541c7b851
Scott, David Alexander
19b5fd34-9974-4ae4-8be0-27a693639e20
Melendez-Torres, G.J.
4b28c1a1-8221-426a-8ee6-f5dddb0e2cd5
27 July 2020
O'Toole, Brian
cd14cb1f-97e3-4f47-b701-1047eb8e1415
Nikram, Elham
42b3d70c-eebc-4e1b-a0d7-23f69e4e8742
Robinson, Sophie
ca6f6393-f165-4a34-98a5-d90541c7b851
Scott, David Alexander
19b5fd34-9974-4ae4-8be0-27a693639e20
Melendez-Torres, G.J.
4b28c1a1-8221-426a-8ee6-f5dddb0e2cd5
O'Toole, Brian, Nikram, Elham, Robinson, Sophie, Scott, David Alexander and Melendez-Torres, G.J.
(2020)
Mepolizumab for treating severe eosinophilic asthma (review of technology appraisal guidance TA431) [ID3750]
(Health Technology Assessment, HTA-NIHR131486)
National Institute for Health and Care Research
62pp.
Record type:
Monograph
(Project Report)
This record has no associated files available for download.
More information
Published date: 27 July 2020
Identifiers
Local EPrints ID: 451278
URI: http://eprints.soton.ac.uk/id/eprint/451278
PURE UUID: d8d34b54-a652-4a5c-a6d9-81562c65f83f
Catalogue record
Date deposited: 16 Sep 2021 16:31
Last modified: 10 Apr 2024 02:03
Export record
Contributors
Author:
Brian O'Toole
Author:
Elham Nikram
Author:
Sophie Robinson
Author:
David Alexander Scott
Author:
G.J. Melendez-Torres
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics